作为抗癌剂的化和替代的piperazines:一个审查
Saumya Singh1, Rajnish Kumar1, Shrishti Tripathi1
1Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, India.
Chemical biology & drug design
|March 6, 2025
概括
皮佩拉衍生物通过抑制细胞循环和血管生成,显示出作为抗癌剂的前景. 本综述探讨了它们的合成和结构-活性关系,以开发具有较少副作用的更有效的癌症药物.
科学领域:
- 药用化学 医学化学
- 有机化学 有机化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症仍然是一个重大的健康挑战,需要开发更安全,更有效的抗癌药物.
- 目前抗癌疗法的局限性包括对健康细胞的毒性和可变的疗效.
- 皮佩拉津部分是一种多功能支架,存在于众多生物活性化合物中.
研究的目的:
- 审查最近在化和替代piperazines的合成方面的进展.
- 探索作为抗癌剂的皮佩拉衍生物的结构-活性关系 (SAR).
- 概述皮佩拉津衍生物与癌症治疗的生物标相互作用的机制.
主要方法:
- 对最近发表的合成方法论的文献综述 对于皮佩拉衍生物的合成方法.
- 对SAR研究的分析,重点关注抗癌活性.
- 检查报告的分子标和皮佩拉基化合物的受体相互作用.
主要成果:
- 皮佩拉衍生物具有多种抗癌性质,包括细胞循环抑制 (G1/S阶段) 和抗血管性作用.
- 皮佩拉津的灵活结合性允许与各种生物点相互作用.
- 最近的合成策略已经扩大了可访问的皮佩拉津结构的曲目.
结论:
- 皮佩拉衍生物代表了抗癌药物开发的一类有前途的化合物.
- 了解SAR和目标相互作用对于设计基于piperazine的新型抗癌剂至关重要.
- 这一审查为药物化学家提供了宝贵的见解,旨在创建更有效的抗癌药物,并改善了安全性.
相关概念视频
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K


